Indonesian pharmaceutical products company, PT SOHO Global Health (SOHO), has received funding from Asian healthcare investment firm Quadria Capital. The firm’s first private equity investment in Indonesia is aimed to increase access to differentiated medicines of high quality within Indonesia and the Southeast Asia region.
According to data from the Ministry of Health 2012, the number of pharmaceutical companies in Indonesia reached 206 companies, 39 of which are multinationals. The average drugs selling at the national level is growing 12-13 per cent annually. More than 70 per cent of the total drug market in Indonesia is dominated by domestic companies.
